Accelerate Diagnostics, Inc. (AXDX) News

Accelerate Diagnostics, Inc. (AXDX): $5.25

0.11 (-2.05%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Filter AXDX News Items

AXDX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest AXDX News From Around the Web

Below are the latest news stories about ACCELERATE DIAGNOSTICS INC that investors may wish to consider to help them evaluate AXDX as an investment opportunity.

Q2 2023 Accelerate Diagnostics Inc Earnings Call

Q2 2023 Accelerate Diagnostics Inc Earnings Call

Yahoo | August 11, 2023

Accelerate Diagnostics (AXDX) Reports Q2 Loss, Misses Revenue Estimates

Accelerate Diagnostics (AXDX) delivered earnings and revenue surprises of -57.33% and 26.98%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | August 10, 2023

Accelerate Diagnostics Reports Second Quarter 2023 Financial Results

Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second quarter for the period ended June 30, 2023.

Yahoo | August 10, 2023

Accelerate Diagnostics Scheduled Call to Review 2023 Second Quarter Results

Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, August 10, 2023, at 4:30 p.m. Eastern Time to review 2023 second quarter results.

Yahoo | July 27, 2023

Accelerate Diagnostics Announces 1-for-10 Reverse Stock Split

Accelerate Diagnostics, Inc., (NASDAQ: AXDX) (the "Company") a leading provider of innovative rapid diagnostic solutions, announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-10. The reverse stock split will become effective at 5:00 p.m. Eastern Time, on July 11, 2023. The Company's common stock will begin trading on a post-split basis at the market open on July 12, 2023, under the Company's existing trading symbol "AXDX". The reverse

Yahoo | July 10, 2023

Is Accelerate Diagnostics (AXDX) Stock Outpacing Its Medical Peers This Year?

Here is how Accelerate Diagnostics (AXDX) and BellRing Brands (BRBR) have performed compared to their sector so far this year.

Yahoo | June 29, 2023

Is Akero Therapeutics (AKRO) Outperforming Other Medical Stocks This Year?

Here is how Akero Therapeutics, Inc. (AKRO) and Accelerate Diagnostics (AXDX) have performed compared to their sector so far this year.

Yahoo | June 13, 2023

Accelerate Diagnostics Announces Successful Completion of Debt Restructuring Support Agreement, Supporting Advancement of Next-Generation Platform Wave

Accelerate Diagnostics, Inc., (NASDAQ: AXDX) a leading provider of innovative rapid diagnostic solutions, has closed the transactions contemplated by the previously announced restructuring support agreement. Through a series of transactions, the company has simplified its capital structure, extended-out its debt maturity 3.5 years and secured $24 million of new funding, providing opportunities for future growth and innovation.

Yahoo | June 13, 2023

Individual investors invested in Accelerate Diagnostics, Inc. (NASDAQ:AXDX) up 45% last week, insiders too were rewarded

Key Insights The considerable ownership by individual investors in Accelerate Diagnostics indicates that they...

Yahoo | June 13, 2023

Is Accelerate Diagnostics (AXDX) Outperforming Other Medical Stocks This Year?

Here is how Accelerate Diagnostics (AXDX) and Cognition Therapeutics, Inc. (CGTX) have performed compared to their sector so far this year.

Yahoo | May 23, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!